1. Home
  2. Labeler Index
  3. Fresenius Kabi Norge As
  4. 66298-8507
  5. NDC Package Code: 66298-8507-4 Moxifloxacin

NDC Package 66298-8507-4 Moxifloxacin

Moxifloxacin Hydrochloride Injection, Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
66298-8507-4
Package Description:
250 mL in 1 BAG
Product Code:
66298-8507
Proprietary Name:
Moxifloxacin
Non-Proprietary Name:
Moxifloxacin Hydrochloride
Substance Name:
Moxifloxacin Hydrochloride
Usage Information:
This medication is a quinolone antibiotic used for eye infections.
11-Digit NDC Billing Format:
66298850704
NDC to RxNorm Crosswalk:
  • RxCUI: 351156 - moxifloxacin 400 MG in 250 ML Injection
  • RxCUI: 351156 - 250 ML moxifloxacin 1.6 MG/ML Injection
  • RxCUI: 351156 - moxifloxacin 400 MG per 250 ML Injection
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Fresenius Kabi Norge As
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • MOXIFLOXACIN HYDROCHLORIDE 400 mg/250mL
    • Pharmacologic Class(es):
  • Quinolone Antimicrobial - [EPC] (Established Pharmacologic Class)
  • Quinolones - [CS]
    • Sample Package:
    No
    FDA Application Number:
    NDA205572
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    08-02-2017
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 66298-8507-4?

    The NDC Packaged Code 66298-8507-4 is assigned to a package of 250 ml in 1 bag of Moxifloxacin, a human prescription drug labeled by Fresenius Kabi Norge As. The product's dosage form is injection, solution and is administered via intravenous form.

    Is NDC 66298-8507 included in the NDC Directory?

    Yes, Moxifloxacin with product code 66298-8507 is active and included in the NDC Directory. The product was first marketed by Fresenius Kabi Norge As on August 02, 2017 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 66298-8507-4?

    The 11-digit format is 66298850704. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-166298-8507-45-4-266298-8507-04